RSSDI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2022

Assessment of the diagnostic accuracy of Vibrasense compared to a biothesiometer and nerve conduction study for screening diabetic peripheral neuropathy

“…The resulting area under the curve (AUC) helps interpret the discriminatory capability of a test and was categorized as follows: Fail (0.50-0.59), Poor (0.60-0.69), Fair (0.70-0.79), Good (0.80-0.89), and Excellent (≥ 0.90) [32]. Some guidelines suggest that a VPT threshold of 25 V strongly predicts future foot ulceration risk [3,33]. Therefore, besides the manufacturer's recommended diagnostic threshold of 15 V, we also conducted an exploratory analysis examining the diagnostic efficacy of Vibrasense against abnormal NCS using a 25 V cut-off.…”

Do We Need Another Guideline on Managing Type 2 Diabetes in India?

“…There are two major clinical practice guidelines or recommendations used in India that provide clinicians some guidance on managing T2D among Asian Indians; a) ICMR (Indian Council for Medical Research) guidelines [4] that were published in 2018, and RSSDI-ESI (Research Society for the Study of Diabetes in India-Endocrine Society of India) Clinical Practice Recommendations published in 2020 which was updated in 2022 by RSSDI [5,6]. The ICMR recommendations are an easy systematic approach to screening, diagnosing, and managing T2D in India.…”

“…However, the ICMR recommendation lacks citations or references for each recommendation [4]. On the other hand, RSSDI is a comprehensive recommendation on screening, diagnosis, and management of T2D for Asian Indians, and recommendations are generated using more than 1300 publications [5,6]. Considering the rapid change in evidence, guidelines must be updated, preferably yearly, and disseminated among clinicians on time to improve diabetes care.…”